Back to search
Scientific Name: Granisetron
Brand Name: Sancuso, Sustol
Company Owner: Strakan international ltd, Akorn inc, App pharmaceuticals llc, Baxter healthcare corp anesthesia and critical care, Bedford laboratories, Claris lifesciences ltd, Dr reddys laboratories inc, Ebewe pharma, Sagent strides llc, Sandoz canada inc, Teva parenteral medicines inc, Watson laboratories inc, Wockhardt usa inc, App pharmaceuticals, Hikma farmaceutica (portugal) sa, Hoffmann la roche inc, Cypress pharmaceutical inc, Apotex inc, Barr laboratories inc, Cipla ltd, Corepharma llc, Dr reddys laboratories ltd, Mylan pharmaceuticals inc, Natco pharma ltd, Orchid healthcare, Roxane laboratories inc, Taro pharmaceuticals usa inc, Teva pharmaceuticals usa
Mechanism Of Action Granisetron is a potent, selective antagonist of 5-HT
Description of the Drug: Granisetron is a 5HT3 antagonist used to treat nausea and vomiting in cancer therapy and postoperatively.
Protein Data Bank:
Source: DrugBank Online – Retrieved 2023-01-23 from